Effectiveness of benzodiazepines: Do they work or not?

Expert Review of Neurotherapeutics

Volumn 8, Issue 8, 2008, Pages 1189-1191

  Lader, Malcolm ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Benzodiazepines; Effectiveness; Efficacy

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; CHLORDIAZEPOXIDE; DIAZEPAM; LORAZEPAM; PLACEBO;

CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG DEPENDENCE; DRUG EFFICACY; DRUG WITHDRAWAL; GENERALIZED ANXIETY DISORDER; HUMAN; METHODOLOGY; PATIENT COMPLIANCE; PSYCHOMOTOR DISORDER; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; EVIDENCE-BASED MEDICINE; HUMANS; MIDDLE AGED; PATIENT DROPOUTS; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 49449103919     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.8.1189     Document Type: Review

References (14)

1. Martin JLR, Sainz-Pardo M, Furukawa TA et al. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J. Psychopharmacol. 21, 774-782 (2007).
2. Kessler RC, DuPont RL, Berglund HU et al. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am. J. Psychiatry 156, 1915-1923 (1999).
3. Nutt D, Argyropoulos S, Hood S et al. Generalized anxiety disorder; a comorbid disease. Eur. Neuropsychopharmacol. 16(Suppl. 2), 109-118 (2006).
4. Wittchen HU, Zhao S, Kessler RC et al. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 51, 355-364 (1994).
5. Schweizer E, Rickels K. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatrica. Scand. Suppl. 393, 95-101 (1998).
6. Rynn MA Brawman-Mintzer O. Generalized anxiety disorder: acute and chronic treatment. CNS Spectr. 9, 716-723 (2004).
7. Struzik L, Vermani M, Coonerty-Femiano A et al. Treatments for generalized anxiety disorder. Expert Rev. Neurother. 4, 285-294 (2004).
8. Mitte K, Noack P, Steil R et al. A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. J. Clin. Psychopharmacology 25, 141-150 (2005).
9. Everitt BS, Wessely S. Clinical Trials in Psychiatry (Second Edition), John Wiley & Sons, Chichester, UK (2008).
10. Hofmann SG, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J. Clin. Psychiatry 69, 621-432 (2008).
11. National Institute for Clinical Excellence (NICE). Clinical Guidelines for the Management of Anxiety (Panic Disorder, With or Without Agoraphobia and Generalised Anxiety) in Adults in Primary, Secondary and Community Care. NICE, London, UK (2004).
12. Barker MJ, Greenwood KM, Jackson M et al. Cognitive effects of long-term benzodiazepine use. CNS Drugs 18, 37-48 (2004).
13. Vasile RG, Bruce SE, Goisman RM et al. Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depression Anxiety 22, 59-67 (2005).
14. Stahl SM. Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. J. Clin. Psychiatry 63, 756-757 (2002).